Suppr超能文献

早幼粒细胞白血病蛋白促进人冠状动脉粥样硬化斑块中平滑肌细胞的表型转换。

Promyelocytic leukemia protein promotes the phenotypic switch of smooth muscle cells in atherosclerotic plaques of human coronary arteries.

机构信息

Institute of Physiology, Charité - Universitätsmedizin, Berlin, Germany.

Institute of Pathology, University Medicine Mainz, Mainz 55131, Germany.

出版信息

Clin Sci (Lond). 2021 Apr 16;135(7):887-905. doi: 10.1042/CS20201399.

Abstract

Promyelocytic leukemia protein (PML) is a constitutive component of PML nuclear bodies (PML-NBs), which function as stress-regulated SUMOylation factories. Since PML can also act as a regulator of the inflammatory and fibroproliferative responses characteristic of atherosclerosis, we investigated whether PML is implicated in this disease. Immunoblotting, ELISA and immunohistochemistry showed a stronger expression of PML in segments of human atherosclerotic coronary arteries and sections compared with non-atherosclerotic ones. In particular, PML was concentrated in PML-NBs from α-smooth muscle actin (α-SMA)-immunoreactive cells in plaque areas. To identify possible functional consequences of PML-accumulation in this cell type, differentiated human coronary artery smooth muscle cells (dHCASMCs) were transfected with a vector containing the intact PML-gene. These PML-transfected dHCASMCs showed higher levels of small ubiquitin-like modifier (SUMO)-1-dependent SUMOylated proteins, but lower levels of markers for smooth muscle cell (SMC) differentiation and revealed more proliferation and migration activities than dHCASMCs transfected with the vector lacking a specific gene insert or with the vector containing a mutated PML-gene coding for a PML-form without SUMOylation activity. When dHCASMCs were incubated with different cytokines, higher PML-levels were observed only after interferon γ (IFN-γ) stimulation, while the expression of differentiation markers was lower. However, these phenotypic changes were not observed in dHCASMCs treated with small interfering RNA (siRNA) suppressing PML-expression prior to IFN-γ stimulation. Taken together, our results imply that PML is a previously unknown functional factor in the molecular cascades associated with the pathogenesis of atherosclerosis and is positioned in vascular SMCs (VSMCs) between upstream IFN-γ activation and downstream SUMOylation.

摘要

早幼粒细胞白血病蛋白 (PML) 是 PML 核体 (PML-NBs) 的组成成分,其作为应激调节 SUMO 化工厂发挥作用。由于 PML 还可以作为动脉粥样硬化特征性炎症和纤维增生反应的调节剂,我们研究了 PML 是否与该疾病有关。免疫印迹、ELISA 和免疫组织化学显示,与人非动脉粥样硬化冠状动脉段相比,动脉粥样硬化冠状动脉段的 PML 表达更强。特别是,PML 集中在斑块区域的 α-平滑肌肌动蛋白 (α-SMA) 免疫反应性细胞的 PML-NBs 中。为了确定 PML 在这种细胞类型中积累的可能功能后果,用含有完整 PML 基因的载体转染分化的人冠状动脉平滑肌细胞 (dHCASMCs)。与转染缺乏特定基因插入的载体或转染编码无 SUMO 化活性的 PML 形式的突变 PML 基因的载体的 dHCASMCs 相比,这些 PML 转染的 dHCASMCs 显示出更高水平的小泛素样修饰物 (SUMO)-1 依赖性 SUMO 化蛋白,但平滑肌细胞 (SMC) 分化标记物的水平更低,并且显示出比 dHCASMCs 更高的增殖和迁移活性。当用不同的细胞因子孵育 dHCASMCs 时,仅在干扰素 γ (IFN-γ) 刺激后观察到更高的 PML 水平,而分化标记物的表达水平较低。然而,在用干扰素 γ 刺激之前用小干扰 RNA (siRNA) 抑制 PML 表达处理的 dHCASMCs 中未观察到这些表型变化。总之,我们的结果表明,PML 是动脉粥样硬化发病机制相关分子级联反应中以前未知的功能因素,位于血管平滑肌细胞 (VSMCs) 中,位于上游 IFN-γ 激活和下游 SUMO 化之间。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验